The Valley Desk

NCT01443845 · Interventional trial

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)

Overall registry status Completed

Phase 4

Conditions COPD, COPD Exacerbation, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Diseases, Lung Diseases, Pulmonary Disease, Respiratory Disorders

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov